4-183444970-A-G
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_017632.4(CDKN2AIP):āc.173A>Gā(p.Asp58Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000429 in 1,610,214 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_017632.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CDKN2AIP | NM_017632.4 | c.173A>G | p.Asp58Gly | missense_variant | 1/3 | ENST00000504169.2 | NP_060102.1 | |
CDKN2AIP | NM_001317343.2 | c.173A>G | p.Asp58Gly | missense_variant | 1/3 | NP_001304272.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CDKN2AIP | ENST00000504169.2 | c.173A>G | p.Asp58Gly | missense_variant | 1/3 | 1 | NM_017632.4 | ENSP00000427108.1 | ||
CDKN2AIP | ENST00000510928.1 | c.173A>G | p.Asp58Gly | missense_variant | 1/2 | 2 | ENSP00000421308.1 | |||
CDKN2AIP | ENST00000302350.4 | c.173A>G | p.Asp58Gly | missense_variant | 1/3 | 2 | ENSP00000303788.4 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152206Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000649 AC: 16AN: 246454Hom.: 0 AF XY: 0.0000820 AC XY: 11AN XY: 134098
GnomAD4 exome AF: 0.0000446 AC: 65AN: 1458008Hom.: 0 Cov.: 31 AF XY: 0.0000662 AC XY: 48AN XY: 724790
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152206Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74354
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 01, 2023 | The c.173A>G (p.D58G) alteration is located in exon 1 (coding exon 1) of the CDKN2AIP gene. This alteration results from a A to G substitution at nucleotide position 173, causing the aspartic acid (D) at amino acid position 58 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at